Patrick M. Forde, Arlene A. Forastiere, Julia D. Ransohoff receive ECOG-ACRIN 2023 scientific leadership and mentorship awards

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Patrick M. Forde

Arlene A. Forastiere

Julia D. Ransohoff

Patrick M. Forde, Arlene A. Forastiere, and Julia D. Ransohoff were named recipients of the ECOG-ACRIN Cancer Research Group 2023 scientific leadership and mentorship awards.

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

The NCI-MATCH trial offers treatment opportunities for adult patients with relapsed, refractory cancers. A new treatment arm (Z1M) is evaluating the immunotherapy combination of relatlimab and nivolumab in patients whose tumors have mismatch repair deficiency and LAG-3 expression and have progressed after anti–PD-1/PD-L1 immunotherapy. 

Login